LuSeed Vascular Appoints Robert Stern to its Board of Directors

Petach-Tikvah, ISRAEL, January 17, 2023- LuSeed Vascular, the developer of an innovative solution for the treatment of brain aneurysms, has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as Vice Chairman of the Board of Directors. 

Mr. Stern currently serves as an advisor to several medical device companies and has been a board member of multiple neurovascular-focused companies, including Flexible Stenting Solutions, Reverse Medical, and Neuravi – all of which have been sold to strategic investors.